Stay updated on Ravulizumab Study in LN/IgAN Clinical Trial
Sign up to get notified when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.

Latest updates to the Ravulizumab Study in LN/IgAN Clinical Trial page
- ChecktodayChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1. The study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check21 days agoChange DetectedThe study record page is currently displaying a 403 error, indicating access is blocked, with the site chrome visible around it.SummaryDifference19%

- Check42 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6 on the page, signaling a minor update to the page’s template or presentation.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, signaling a new release of the page template with likely small fixes or improvements rather than substantive content changes.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing Revision: v3.6.3, indicating the study page has been updated to the latest revision.SummaryDifference0.0%

- Check100 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3. This indicates a new page release rather than a change to the study details.SummaryDifference0.0%

Stay in the know with updates to Ravulizumab Study in LN/IgAN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.